146 related articles for article (PubMed ID: 36008376)
21. Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche.
Han HH; Kim BG; Lee JH; Kang S; Kim JE; Cho NH
Endocr Relat Cancer; 2016 Aug; 23(8):609-23. PubMed ID: 27353038
[TBL] [Abstract][Full Text] [Related]
22. Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity.
Strietz J; Stepputtis SS; Follo M; Bronsert P; Stickeler E; Maurer J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670400
[TBL] [Abstract][Full Text] [Related]
23. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.
Johnson J; Rychahou P; Sviripa VM; Weiss HL; Liu C; Watt DS; Evers BM
PLoS One; 2019; 14(3):e0209392. PubMed ID: 30875375
[TBL] [Abstract][Full Text] [Related]
24. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells.
Yin K; Yin W; Wang Y; Zhou L; Liu Y; Yang G; Wang J; Lu J
Oncotarget; 2016 Apr; 7(17):24537-48. PubMed ID: 27014911
[TBL] [Abstract][Full Text] [Related]
25. Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.
Kikuchi K; McNamara KM; Miki Y; Moon JY; Choi MH; Omata F; Sakurai M; Onodera Y; Rai Y; Ohi Y; Sagara Y; Miyashita M; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res Treat; 2017 Dec; 166(3):709-723. PubMed ID: 28831645
[TBL] [Abstract][Full Text] [Related]
26. Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer.
Kim RS; Avivar-Valderas A; Estrada Y; Bragado P; Sosa MS; Aguirre-Ghiso JA; Segall JE
PLoS One; 2012; 7(4):e35569. PubMed ID: 22530051
[TBL] [Abstract][Full Text] [Related]
27. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R
Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384
[TBL] [Abstract][Full Text] [Related]
28. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.
Huang J; Woods P; Normolle D; Goff JP; Benos PV; Stehle CJ; Steinman RA
Breast Cancer Res Treat; 2017 Jan; 161(2):229-243. PubMed ID: 27853906
[TBL] [Abstract][Full Text] [Related]
30. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.
Wang Q; Cheng Y; Wang Y; Fan Y; Li C; Zhang Y; Wang Y; Dong Q; Ma Y; Teng YE; Qu X; Liu Y
BMC Cancer; 2017 Jul; 17(1):492. PubMed ID: 28724364
[TBL] [Abstract][Full Text] [Related]
31. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM
Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095
[TBL] [Abstract][Full Text] [Related]
32. Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
Basudhar D; Glynn SA; Greer M; Somasundaram V; No JH; Scheiblin DA; Garrido P; Heinz WF; Ryan AE; Weiss JM; Cheng RYS; Ridnour LA; Lockett SJ; McVicar DW; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):13030-13035. PubMed ID: 29087320
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer.
Yamamoto M; Sakane K; Tominaga K; Gotoh N; Niwa T; Kikuchi Y; Tada K; Goshima N; Semba K; Inoue JI
Cancer Sci; 2017 Jun; 108(6):1210-1222. PubMed ID: 28371195
[TBL] [Abstract][Full Text] [Related]
34. Quantitative proteomics reveals ER-α involvement in CD146-induced epithelial-mesenchymal transition in breast cancer cells.
Zeng Q; Zhang P; Wu Z; Xue P; Lu D; Ye Z; Zhang X; Huang Z; Feng J; Song L; Yang D; Jiang T; Yan X
J Proteomics; 2014 May; 103():153-69. PubMed ID: 24704855
[TBL] [Abstract][Full Text] [Related]
35. Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.
de Boo L; Cimino-Mathews A; Lubeck Y; Daletzakis A; Opdam M; Sanders J; Hooijberg E; van Rossum A; Loncova Z; Rieder D; Trajanoski Z; Vollebergh M; Sobral-Leite M; van de Vijver K; Broeks A; van der Wiel R; van Tinteren H; Linn S; Horlings HM; Kok M
Eur J Cancer; 2020 Mar; 127():240-250. PubMed ID: 31956037
[TBL] [Abstract][Full Text] [Related]
36. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
37. The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer.
Fukuoka M; Ichikawa Y; Osako T; Fujita T; Baba S; Takeuchi K; Tsunoda N; Ebata T; Ueno T; Ohno S; Saitoh N
Cancer Sci; 2022 Jul; 113(7):2336-2351. PubMed ID: 35415910
[TBL] [Abstract][Full Text] [Related]
38. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of ovarian stimulation and fertility preservation in breast cancer patients with different hormonal receptor profiles.
Balayla J; Tulandi T; Buckett W; Holzer H; Steiner N; Shrem G; Volodarsky-Perel A
J Assist Reprod Genet; 2020 Apr; 37(4):913-921. PubMed ID: 32144524
[TBL] [Abstract][Full Text] [Related]
40. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
